Cellular Mechanisms Which Distinguish between Hormone‐ and Antihormone‐Activated Estrogen Receptor

Annals of the New York Academy of Sciences

Volumn 761, Issue 1, 1995, Pages 121-137

  McDonnell, Donald P ^a   Dana, Sharon L ^b   HOENER, PATRICIA A ^b   LIEBERMAN, BENJAMIN A ^a   IMHOF, MARKUS O ^a   STEIN, ROBERT B ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; CELL PROTEIN; CLOMIFENE; ESTROGEN; ESTROGEN RECEPTOR; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE; NAFOXIDINE; SEX HORMONE; STEROID RECEPTOR; TAMOXIFEN; TRANSACTIVATOR PROTEIN;

AMINO ACID SEQUENCE; BREAST CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DRUG RESISTANCE; GENE SEQUENCE; GENETIC TRANSCRIPTION; HORMONAL THERAPY; HUMAN; HUMAN CELL; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 0029127132     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1995.tb31374.x     Document Type: Article

References (44)

1. New molecular markers of prognosis in breast cancer
2. Steroid hormone receptors in breast cancer
3. Frequency and distribution of estrogen receptor positive cells in normal, nonlactating human breast
4. Estradiol‐stimulated growth of MCF‐7 tumors implanted in athymic nude mice: a model to study the tumoristatic action of tamoxifen
5. Tamoxifen in pre‐menopausal patients with metatastic breast cancer: a review
6. Estrogen receptor mutations in breast cancer
7. Tamoxifen and the isomers of 4‐hydroxytamoxifen in tamoxifen‐resistant tumors from breast cancer patients
8. The steroid and thyroid hormone receptor superfamily
9. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D
10. The steroid receptor superfamily
11. Nuclear hormone receptors as targets for new drug discovery
12. Mechanism of action of hormone antagonists
13. Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen
14. Structure‐function analysis of the hormone binding domains of the human estrogen receptor by region‐specific mutagenesis and phenotypic screening in yeast
15. Mechanism of RU486 antagonism is dependent on the conformation of the carboxyl‐terminal tail of the human progesterone receptor
16. A single amino acid determines the sensitivity of progesterone receptors to RU486
17. Steroid receptors and their associated proteins
18. Signal transduction by steroid hormones: nuclear localization is differentially regulated in estrogen and glucocorticoid receptors
19. Hormone free mouse glucocorticoid receptors overexpressed in Chinese hamster ovary cells are localized to the nucleus and are associated with both hsp70 and hsp90
20. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation
21. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain
22. Cooperative binding of estrogen receptor to imperfect estrogen‐responsive DNA elements correlates with their synergistic hormone‐dependent enhancer activity
23. Cooperative binding of steroid hormone receptors contibutes to transcriptional synergism at target enhancer elements
24. The estrogen receptor binds tightly to its responsive element as a ligand‐induced homodimer
25. Estrogen receptor‐associated proteins: possible mediators of hormone‐induced transcription
26. Cross‐coupling of signal transduction pathways: zinc finger meets leucine zipper
27. Modulation of the ligand‐independent activation of the human estrogen receptor by hormone and antihormone
28. Dopamine activation of an orphan of the steroid receptor superfamily
29. Convergent pathways for steroid hormone‐ and neurotransmitter‐induced rat sexual behavior
30. Peptide growth factors elicit estrogen receptor dependent activation of an estrogen‐responsive element
31. Stimulation of estrogen receptor‐mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin‐like growth factor‐1
32. Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens
33. Coupling of dual signalling pathways: epidermal growth factor action involves the estrogen receptor
34. Human estrogen receptor transcriptional capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
35. Role of the two activating domains of the oestrogen receptor in the cell‐type and promoter‐context dependent agonistic activity of the anti‐oestrogen 4‐hydroxytamoxifen
36. Ligand‐dependent and independent functions of the transactivation regions of the human estrogen receptor in yeast
37. Identification of a negative regulatory function for steroid receptors
38. The global transcriptional regulators, SSN6 and TUP1, play distinct roles in the establishment of a repressive chromatin structure
39. SSN6‐TUP1 is a general repressor of transcription in yeast
40. The CYC8 and TUP1 proteins involved in glucose repression in Saccharomyces cerevisiae are associated in a protein complex
41. Functional dissection of the yeast CYC8‐TUP1 transcriptional co‐repressor complex
42. Transcriptional repression directed by the yeast α2 protein in vitro
43. Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells
44. In situ distinction between steroid receptor binding and transactivation at a target gene